[1. deGroen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999; 341:1368-78.10.1056/NEJM199910283411807]Search in Google Scholar
[2. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev. 1995; 4:475-83.]Search in Google Scholar
[3. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3:33-42.10.1038/ncpgasthep0389]Open DOISearch in Google Scholar
[4. West J, Wood H, Logan RFA, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer. 2006; 94:1751-8.10.1038/sj.bjc.6603127]Search in Google Scholar
[5. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005; 366:1303-14.10.1016/S0140-6736(05)67530-7]Search in Google Scholar
[6. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001; 22: 1111-7.10.1093/carcin/22.8.1111]Open DOISearch in Google Scholar
[7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275:218-20.10.1126/science.275.5297.218]Search in Google Scholar
[8. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell specific alteration of the cell cycle. Biochem Pharmacol. 2002; 64:1375-86.10.1016/S0006-2952(02)01296-0]Search in Google Scholar
[9. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalingdependent apoptosis in human tumor cells. Blood. 1998; 92:996-1002.10.1182/blood.V92.3.996]Search in Google Scholar
[10. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, et al. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep. 2004; 11:441-6.10.3892/or.11.2.441]Search in Google Scholar
[11. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, Suh SI, et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U 937 cells. Cancer Lett. 2001; 163:43-9.10.1016/S0304-3835(00)00658-3]Search in Google Scholar
[12. Roncoroni L, Elli L, Dolfini E, Erba E, Dogliotti E, Terrani C, et al. Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line. Liver International. 2008; 28:1426-36.10.1111/j.1478-3231.2008.01749.x]Open DOISearch in Google Scholar
[13. Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, et al. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol. 2005; 11: 2748-53.10.3748/wjg.v11.i18.2748]Open DOISearch in Google Scholar
[14. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol. 2005; 11:3392-7.10.3748/wjg.v11.i22.3392]Open DOISearch in Google Scholar
[15. Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol. 2008; 14: 1491-7.10.3748/wjg.14.1491]Open DOISearch in Google Scholar
[16. Hahnvajanawong C, Boonyanugomol W, Nasomyon T, Loilome W, Namwat N, Anantachoke N, et al. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. World J Gastroenterol. 2010; 16:2235-43.10.3748/wjg.v16.i18.2235]Open DOISearch in Google Scholar
[17. Nomura M, Nomura N, Newcomb EW, Lukyanov Y, Tamasdan C, Zagzag D. Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. J Cell Physiol. 2004; 201:374-84.10.1002/jcp.20090]Search in Google Scholar
[18. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC biotechnol. 2005; 5:12.10.1186/1472-6750-5-12]Open DOISearch in Google Scholar
[19. Herrmann M, Lorenz HM, VolI R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994; 22:5506-7.10.1093/nar/22.24.5506]Open DOISearch in Google Scholar
[20. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 2003; 190:157-63.10.1016/S0304-3835(02)00676-6]Open DOISearch in Google Scholar
[21. Compton MM. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 1992; 11:105-19.10.1007/BF000480581327565]Open DOISearch in Google Scholar
[22. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellon EA. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl. 2007; 28:282-93.10.2164/jandrol.106.000968]Open DOISearch in Google Scholar
[23. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, et al. Biliary adenocarcinoma characterisation of three new human tumor cell lines. J Hepatol. 1985; 1:579-96.10.1016/S0168-8278(85)80002-7]Open DOISearch in Google Scholar
[24. Kim YA, Lee WH, Choi TH, Rhee SH, Park KY, Choi YH. Involvement of p21WAF1/CIP1, pRB, Bax and NF-κB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A 549 cells. Int J Oncol. 2003; 23:1143-9.10.3892/ijo.23.4.1143]Search in Google Scholar
[25. Delmas D, Jannin B, Malki MC, Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep. 2000; 7: 847-52.10.3892/or.7.4.847]Search in Google Scholar
[26. Larrosa M, Tomas-Barberan FA, Espin JC. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem. 2003; 51:4576-84.10.1021/jf030073c]Search in Google Scholar
[27. Cooper GM, Hausman RE. The Cell: A Molecular Approach. 3rd ed. Washington DC: ASM Press; 2004.]Search in Google Scholar
[28. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995; 6:387-400.10.1091/mbc.6.4.387]Open DOISearch in Google Scholar
[29. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002; 1:639-49.]Search in Google Scholar
[30. Kim YA, Rhee SH, Park KY, Choi YH. Antiproliferative effect of resveratrol in human prostate carcinoma cells. J Med Food. 2003; 6:273-80.10.1089/109662003772519813]Open DOISearch in Google Scholar
[31. Delmas D, Passilly-Degrace P, Jannin B, Malki MC, Latruffe N. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med. 2002; 10:193-9.10.3892/ijmm.10.2.193]Search in Google Scholar
[32. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998; 141:875-85.10.1083/jcb.141.4.875]Search in Google Scholar
[33. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G, Lee SJ. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 1999; 140:1-10.10.1016/S0304-3835(99)00039-7]Open DOISearch in Google Scholar
[34. Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc). 2005; 70:231-9.10.1007/s10541-005-0105-4]Search in Google Scholar
[35. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosisinducing factor (AIF): key to the conserved caspaseindependent pathways of cell death ? J Cell Sci. 2002; 115:4727-34.10.1242/jcs.00210]Open DOISearch in Google Scholar
[36. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry. 2001; 40:1117-23.10.1021/bi001603q]Search in Google Scholar
[37. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, et al. Bcl-2 overexpression attenuates resveratrolinduced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis. 2001; 22:1633-9.10.1093/carcin/22.10.1633]Search in Google Scholar
[38. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003; 72: 2219-33.10.1016/S0024-3205(03)00096-1]Open DOISearch in Google Scholar
[39. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, et al. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharm. 2007; 224:274-83.10.1016/j.taap.2006.12.025208312317306316]Search in Google Scholar
[40. Frampton GA, Lazcano EA, Li H, Mohamad A, DeMorrow S. Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab Invest. 2010; 90:1325-38.10.1038/labinvest.2010.99292155420458282]Open DOISearch in Google Scholar
[41. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010; 70:9003-11.10.1158/0008-5472.CAN-10-2364298288420935227]Open DOISearch in Google Scholar
[42. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5:493-506. 10.1038/nrd206016732220]Open DOISearch in Google Scholar